Literature DB >> 22078269

MUC1 mucin is expressed on human T-regulatory cells: function in both co-stimulation and co-inhibition.

Jeffrey D Konowalchuk1, Babita Agrawal.   

Abstract

MUC1 mucin, an important protein of epithelial cells and epithelial-derived carcinomas, is also expressed on activated T cells, showing both positive and negative regulatory functions. It is currently unknown whether MUC1 is a true regulatory protein of T cells and what conditions lead to MUC1 co-stimulation versus co-inhibition. We have found that MUC1 is expressed on the majority of T-regulatory cells (CD4(+)/CD25(+)/FoxP3(+)) in humans (>90%) and that CD3/MUC1 co-stimulation leads to an increased number of T-regulatory cells. We also discovered that the immunoregulatory function is dependent upon the number of accessory (CD3(-)) cells present, with co-inhibition occurring with <5-10% accessory cells while co-stimulation begins with a reconstitution of ~50% accessory cells. Co-inhibition was also found to not be the result of the apoptosis but a separate and unknown pathway. This data further characterizes MUC1 as an immunoregulatory protein of T cells capable of giving a positive or negative stimulus.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22078269     DOI: 10.1016/j.cellimm.2011.10.012

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  8 in total

Review 1.  Cellular and molecular biology of airway mucins.

Authors:  Erik P Lillehoj; Kosuke Kato; Wenju Lu; Kwang C Kim
Journal:  Int Rev Cell Mol Biol       Date:  2013       Impact factor: 6.813

Review 2.  Tecemotide: an antigen-specific cancer immunotherapy.

Authors:  Gregory T Wurz; Chiao-Jung Kao; Michael Wolf; Michael W DeGregorio
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

3.  Higher susceptibility to experimental autoimmune encephalomyelitis in Muc1-deficient mice is associated with increased Th1/Th17 responses.

Authors:  Jui-Hung Yen; Shuyun Xu; Yong Sung Park; Doina Ganea; Kwang Chul Kim
Journal:  Brain Behav Immun       Date:  2012-12-20       Impact factor: 7.217

Review 4.  MUC1: The First Respiratory Mucin with an Anti-Inflammatory Function.

Authors:  Kosuke Kato; Erik P Lillehoj; Wenju Lu; Kwang Chul Kim
Journal:  J Clin Med       Date:  2017-11-29       Impact factor: 4.241

Review 5.  MUC1 Mucin: A Putative Regulatory (Checkpoint) Molecule of T Cells.

Authors:  Babita Agrawal; Nancy Gupta; Jeffrey D Konowalchuk
Journal:  Front Immunol       Date:  2018-10-22       Impact factor: 7.561

Review 6.  New therapeutic targets for cancer: the interplay between immune and metabolic checkpoints and gut microbiota.

Authors:  Babita Agrawal
Journal:  Clin Transl Med       Date:  2019-08-27

7.  MUC1 (CA27.29) before and after Chemotherapy and Prognosis in High-Risk Early Breast Cancer Patients.

Authors:  Hanna Huebner; Lothar Häberle; Volkmar Müller; Iris Schrader; Ralf Lorenz; Helmut Forstbauer; Visnja Fink; Fabienne Schochter; Inga Bekes; Sven Mahner; Julia Jückstock; Naiba Nabieva; Andreas Schneeweiss; Hans Tesch; Sara Y Brucker; Jens-Uwe Blohmer; Tanja N Fehm; Georg Heinrich; Mahdi Rezai; Matthias W Beckmann; Peter A Fasching; Wolfgang Janni; Brigitte Rack
Journal:  Cancers (Basel)       Date:  2022-03-28       Impact factor: 6.639

8.  Membrane-Tethered Mucin 1 Is Stimulated by Interferon and Virus Infection in Multiple Cell Types and Inhibits Influenza A Virus Infection in Human Airway Epithelium.

Authors:  Ethan Iverson; Kira Griswold; Daniel Song; Talita B Gagliardi; Kajal Hamidzadeh; Mehmet Kesimer; Sanju Sinha; Melissa Perry; Gregg A Duncan; Margaret A Scull
Journal:  mBio       Date:  2022-06-14       Impact factor: 7.786

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.